You have selected the view in French
Descriptor English: | Bupivacaine | ||||
Descriptor Spanish: |
Bupivacaína
| ||||
Descriptor Portuguese: | Bupivacaína | ||||
Descriptor French: | Bupivacaïne | ||||
Entry term(s): |
Bupivacaïne anhydre Carbonate de bupivacaïne Chlorhydrate de bupivacaïne |
||||
Tree number(s): |
D02.065.199.239 D02.092.146.113.239 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D002045 | ||||
Scope note: | A widely used local anesthetic agent. |
||||
Allowable Qualifiers: |
AA analogues et dérivés AD administration et posologie AE effets indésirables AG agonistes AI antagonistes et inhibiteurs AN analyse BL sang CF liquide cérébrospinal CH composition chimique CL classification CS synthèse chimique EC économie HI histoire IM immunologie IP isolement et purification ME métabolisme PD pharmacologie PK pharmacocinétique PO intoxication RE effets des radiations SD ressources et distribution ST normes TO toxicité TU usage thérapeutique UR urine |
||||
Pharm Action: |
Anesthetics, Local |
||||
Registry Number: | Y8335394RO | ||||
CAS Type 1 Name: | 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)- | ||||
Related: |
Ropivacaïne
MeSH | ||||
DeCS ID: | 2077 | ||||
Unique ID: | D002045 | ||||
NLM Classification: | QV 110 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1973/01/01 | ||||
Date of Entry: | 1999/01/01 | ||||
Revision Date: | 2018/01/11 |
-
-
PRODUITS CHIMIQUES ET PHARMACEUTIQUES
Composés chimiques organiques [D02]Composés chimiques organiques -
PRODUITS CHIMIQUES ET PHARMACEUTIQUES
Composés chimiques organiques [D02]Composés chimiques organiques
|
Bupivacaïne
- Preferred
Carbonate de bupivacaïne
- Narrower
Chlorhydrate de bupivacaïne
- Narrower
Bupivacaïne anhydre
- Narrower
Concept UI |
M0003045 |
Preferred term | Bupivacaïne |
Concept UI |
M0003046 |
Preferred term | Carbonate de bupivacaïne |
Concept UI |
M0330885 |
Preferred term | Chlorhydrate de bupivacaïne |
Concept UI |
M0330886 |
Preferred term | Bupivacaïne anhydre |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey